Takeda Pharmaceutical Co. announces on Tuesday that it has obtained consent from the U.S. Food and Drug Administration for its new diabetes drug, reports The Associated Press.
Actoplus Met is a single tablet that merges Takeda's two existing diabetes drugs, Actos and Metformin. Takeda Pharmaceuticals North America Inc. will sell the tablet in the United States starting in October
